RUNX1 and neoplasm: Given our in vitro findings, MUC13 knockdown counteracted the proliferative, migratory, and invasive effects induced by RUNX1 on colorectal cancer cells, prompting a deeper exploration of MUC13's role in RUNX1-driven in vivo tumor progression and metastasis.